CDXS
Price
$2.40
Change
+$0.05 (+2.13%)
Updated
Jun 11, 04:59 PM (EDT)
Capitalization
213.61M
49 days until earnings call
Intraday BUY SELL Signals
SEER
Price
$1.69
Change
-$0.00 (-0.00%)
Updated
Jun 11, 04:59 PM (EDT)
Capitalization
92.92M
56 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CDXS vs SEER

Header iconCDXS vs SEER Comparison
Open Charts CDXS vs SEERBanner chart's image
CDXS vs SEER Comparison Chart in %
View a ticker or compare two or three
VS
CDXS vs. SEER commentary
Jun 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDXS is a StrongBuy and SEER is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 12, 2026
Stock price -- (CDXS: $2.35 vs. SEER: $1.69)
Brand notoriety: CDXS and SEER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDXS: 58% vs. SEER: 21%
Market capitalization -- CDXS: $213.61M vs. SEER: $92.92M
CDXS [@Biotechnology] is valued at $213.61M. SEER’s [@Biotechnology] market capitalization is $92.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.59B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDXS’s FA Score shows that 0 FA rating(s) are green whileSEER’s FA Score has 1 green FA rating(s).

  • CDXS’s FA Score: 0 green, 5 red.
  • SEER’s FA Score: 1 green, 4 red.
According to our system of comparison, CDXS is a better buy in the long-term than SEER.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDXS’s TA Score shows that 5 TA indicator(s) are bullish while SEER’s TA Score has 5 bullish TA indicator(s).

  • CDXS’s TA Score: 5 bullish, 4 bearish.
  • SEER’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CDXS is a better buy in the short-term than SEER.

Price Growth

CDXS (@Biotechnology) experienced а -13.60% price change this week, while SEER (@Biotechnology) price change was -9.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.28%. For the same industry, the average monthly price growth was -4.36%, and the average quarterly price growth was -1.72%.

Reported Earning Dates

CDXS is expected to report earnings on Jul 30, 2026.

SEER is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-4.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDXS($214M) has a higher market cap than SEER($92.9M). CDXS YTD gains are higher at: 44.172 vs. SEER (-7.650). CDXS has higher annual earnings (EBITDA): -21.2M vs. SEER (-68.48M). SEER has more cash in the bank: 167M vs. CDXS (65.1M). SEER has less debt than CDXS: SEER (23M) vs CDXS (72.9M). CDXS has higher revenues than SEER: CDXS (78.1M) vs SEER (14.7M).
CDXSSEERCDXS / SEER
Capitalization214M92.9M230%
EBITDA-21.2M-68.48M31%
Gain YTD44.172-7.650-577%
P/E RatioN/AN/A-
Revenue78.1M14.7M531%
Total Cash65.1M167M39%
Total Debt72.9M23M317%
FUNDAMENTALS RATINGS
CDXS: Fundamental Ratings
CDXS
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDXSSEER
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 15 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 7 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CDXS
Daily Signal:
Gain/Loss:
SEER
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGPSX44.36N/A
N/A
ProFunds Large Cap Growth Svc
PRCEX30.73N/A
N/A
Principal Real Estate Securities C
GCASX50.88N/A
N/A
Gabelli Small Cap Growth A
TPAIX46.61N/A
N/A
Timothy Plan Israel Common Values A
MRRGX32.37N/A
N/A
Meridian Growth Institutional

SEER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SEER has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SEER jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEER
1D Price
Change %
SEER100%
N/A
AXON - SEER
56%
Loosely correlated
-1.09%
ARRY - SEER
47%
Loosely correlated
-7.70%
RNA - SEER
40%
Loosely correlated
-0.77%
DNA - SEER
38%
Loosely correlated
-3.76%
VCYT - SEER
35%
Loosely correlated
-2.17%
More